TECHNICAL FIELD
The invention relates to a pharmaceutical composition comprising canavanine, and a method treatment of cancer, particularly pancreatic cancer, with L-canavanine.
BACKGROUND
More than 26,000 people die each year in our country from pancreatic adenocarcinoma (1, see numbered references